NV
Northpond Ventures Portfolio holdings
AUM
$43.7M
This Quarter Return
-20.87%
1 Year Return
-34.02%
3 Year Return
-71.84%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(+388%)
Cap. Flow
+$80.9M
Cap. Flow
% of AUM
78.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Kyverna Therapeutics
KYTX
|
$80.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kyverna Therapeutics
KYTX
$160M
| $80.9M | 78.8% | +3,255,426 | New | +$80.9M |
|
|
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
| $14.4M | 14% | 4,214,498 | – | – |
|
|
TBIO
3
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $4.33M | 4.22% | 9,844,130 | – | – |
|
4
Candel Therapeutics
CADL
$318M
| $3.06M | 2.98% | 1,935,215 | – | – |
|